Business Operations:

Sector: Consumer Defensive
Industry: Household & Personal Products

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; water-filtration products under the Brita brand; and natural personal care products under the Burt's Bees brand in the United States. The International segment provides laundry additives, home care products, bags and wraps, cat litter products, water-filtration systems, professional cleaning and disinfecting products, natural personal care products, food, grilling products, and digestive health products internationally primarily under the Clorox, Glad, Poett, Brita, Burt's Bees, Pine-Sol, Ever Clean, Clorinda, Chux and Fresh Step Brands. It also offers vitamins, minerals, and supplement products under the Natural Vitality, RenewLife, NeoCell, and Rainbow Light brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

Revenue projections:

CLX's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.

Financial Ratios:

currentRatio	0.658000
forwardPE	12.882173
debtToEquity	2221.429000
earningsGrowth	-0.501000
revenueGrowth	-0.020000
grossMargins	0.423210
operatingMargins	0.128850
trailingEps	4.770000
forwardEps	6.260590

CLX's current ratio being 0.658 indicates that the company's cash reserves and current assets may not be enough to cover its short-term debt. This raises potential liquidity concerns, suggesting CLX might need to secure additional funding to meet its obligations.
CLX's Forward PE is at a healthy level, indicating that the stock price is well-positioned relative to its earnings. With the stock not being overvalued, there remains room for future growth, suggesting a balanced opportunity for investors seeking potential upside.
The Clorox Company's high debt-to-equity ratio indicates a high level of leverage, meaning the company relies significantly on debt for financing. This can increase financial risk, particularly in times of economic instability or reduced profitability.
CLX's low growth in earnings and revenue indicates a potential decline in profits. This suggests that the company could be facing financial challenges, making it harder to sustain its current profit margins.
CLX's negative gross and operating margins indicate that the company is not generating profit from either production or day-to-day operations. This could suggest cost overruns or declining revenue, impacting its financial stability.
The Clorox Company's forward EPS is greater than its trailing EPS, indicating that the company is expected to deliver higher profitability this year. This suggests that The Clorox Company is projected to improve its earnings, reflecting positive growth compared to last year's financial performance.

Price projections:

The price of The Clorox Company has consistently been close to the lower limit of expectations. This trend may point to challenges in the company's performance, leading to concerns about its future growth potential.

Insider Transactions:

1 CLX stock sales were completed, with market price of 124.62999725341797.2 separate purchases of CLX stock were made, while market price was at 95.02000045776367 per share.The transactions conducted by insiders do not indicate any significant pattern, leaving little to infer about the company’s strategic moves.

Recommendation changes over time:

Analysts have recently developed a sell bias for CLX, suggesting caution when making investment decisions. Investors are advised to rely on a broad range of market indicators rather than solely on this bias to ensure a more comprehensive understanding of the stock's potential before taking action.